U.S. Stock Earnings Reports & Market News
Key Metrics Metric Q3 2025 Q3 2024 Change Revenue $1.2 billion $1.04 billion +15.2% Net Income $150 million $130 million +15.4% Gross Profit $600 million $520 million +15.4% Operating Income $250 million $210 million +19.0% EPS (Diluted) $0.45 $0.39 +15.4%…
Executive Summary In FY2024, Regencell Bioscience Holdings Limited reported a net loss of $4.30 million, representing a 26.5% improvement compared to the previous year’s net loss of $5.87 million. Despite ongoing operational challenges, the company demonstrated a significant reduction in…
Executive Summary Tilray Inc, trading under the ticker TLRY, reported its fiscal third quarter of 2025 with a total revenue of $596.8 million, representing a slight decrease of 6.7% compared to the prior year quarter. The company experienced a significant…
Executive Summary Amneal Pharmaceuticals Inc (AMRX) reported its fiscal second quarter of 2025 with notable improvements in revenue and net loss reduction. The company’s revenue increased by 15% compared to the previous quarter, driven by higher sales across key product…
Executive Summary Amneal Pharmaceuticals Inc (NASDAQ: AMRX) reported a significant turnaround in its financial performance for the first quarter of 2025. The company achieved a 134% increase in net income compared to the prior year, driven by improved operational efficiency…
Executive Summary Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) reported its fiscal year 2024 results, demonstrating a significant revenue growth of 17.0% compared to FY2023, reaching approximately $2.79 billion. Despite ongoing challenges, the company narrowed its net loss to $116.9 million from…
Key Metrics (Comparative Overview) Metric Q2 2025 Q2 2024 Change YoY % Six Months 2025 Six Months 2024 Change YoY % Net Revenue (USD Thousands) 210,950 193,771 +17,179 +8.9% 410,994 370,720 +40,274 +10.9% Gross Profit (USD Thousands) 61,220 47,409 +13,811…
Key Metrics Metric Q1 2025 Q1 2024 YoY Change QoQ Change Net Revenue (USD Thousands) 200,044 176,949 13.2% 13.2% Gross Profit (USD Thousands) 59,706 44,196 34.9% 34.9% Operating Loss (USD Thousands) -36,570 -34,362 -6.4% -6.4% Net Loss (USD Thousands) -34,652…
Key Metrics Metric FY 2024 FY 2023 YoY Change Net Revenue (USD Millions) 789 627 +26.0% Gross Profit (USD Millions) 223 147 +51.6% Operating Loss (USD Millions) -175 -1,369 Improvement Net Loss (USD Millions) -222 -1,443 Significant reduction EPS (USD,…